289 related articles for article (PubMed ID: 15258718)
1. Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.
Stein MB; Pollack MH; Bystritsky A; Kelsey JE; Mangano RM
Psychopharmacology (Berl); 2005 Jan; 177(3):280-8. PubMed ID: 15258718
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.
Liebowitz MR; Mangano RM; Bradwejn J; Asnis G;
J Clin Psychiatry; 2005 Feb; 66(2):238-47. PubMed ID: 15705011
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Liebowitz MR; Gelenberg AJ; Munjack D
Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
Rickels K; Mangano R; Khan A
J Clin Psychopharmacol; 2004 Oct; 24(5):488-96. PubMed ID: 15349004
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
Katz IR; Reynolds CF; Alexopoulos GS; Hackett D
J Am Geriatr Soc; 2002 Jan; 50(1):18-25. PubMed ID: 12028242
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
Davidson JR; DuPont RL; Hedges D; Haskins JT
J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
[TBL] [Abstract][Full Text] [Related]
9. Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.
Nimatoudis I; Zissis NP; Kogeorgos J; Theodoropoulou S; Vidalis A; Kaprinis G
Int Clin Psychopharmacol; 2004 Nov; 19(6):331-6. PubMed ID: 15486518
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.
Pollack M; Mangano R; Entsuah R; Tzanis E; Simon NM; Zhang Y
Psychopharmacology (Berl); 2007 Oct; 194(2):233-42. PubMed ID: 17589833
[TBL] [Abstract][Full Text] [Related]
11. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
Pollack MH; Van Ameringen M; Simon NM; Worthington JW; Hoge EA; Keshaviah A; Stein MB
Am J Psychiatry; 2014 Jan; 171(1):44-53. PubMed ID: 24399428
[TBL] [Abstract][Full Text] [Related]
12. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
Davidson J; Baldwin D; Stein DJ; Kuper E; Benattia I; Ahmed S; Pedersen R; Musgnung J
Arch Gen Psychiatry; 2006 Oct; 63(10):1158-65. PubMed ID: 17015818
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.
Rynn MA; Riddle MA; Yeung PP; Kunz NR
Am J Psychiatry; 2007 Feb; 164(2):290-300. PubMed ID: 17267793
[TBL] [Abstract][Full Text] [Related]
14. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
Bose A; Korotzer A; Gommoll C; Li D
Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.
Rickels K; Pollack MH; Sheehan DV; Haskins JT
Am J Psychiatry; 2000 Jun; 157(6):968-74. PubMed ID: 10831478
[TBL] [Abstract][Full Text] [Related]
16. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
17. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
Kroenke K; Messina N; Benattia I; Graepel J; Musgnung J
J Clin Psychiatry; 2006 Jan; 67(1):72-80. PubMed ID: 16426091
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
Liebowitz MR; Asnis G; Mangano R; Tzanis E
J Clin Psychiatry; 2009 Apr; 70(4):550-61. PubMed ID: 19358784
[TBL] [Abstract][Full Text] [Related]
19. Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release.
Boyer P; Mahé V; Hackett D
Eur Psychiatry; 2004 Aug; 19(5):272-9. PubMed ID: 15276659
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
Silverstone PH; Salinas E
J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]